Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Ihab Kamel to Aged, 80 and over

This is a "connection" page, showing publications Ihab Kamel has written about Aged, 80 and over.

 
Connection Strength
  
 
 
1.361
  
  1. Rezvani Habibabadi R, Khoshpouri P, Ghadimi M, Shaghaghi M, Ameli S, Hazhirkarzar B, Pandey P, Aliyari Ghasabeh M, Pandey A, Kamel IR. Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography. Eur Radiol. 2020 Mar; 30(3):1609-1615.
    View in: PubMed
    Score: 0.063
  2. Wang Y, Shen Y, Hu X, Li Z, Feng C, Hu D, Kamel IR. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer. AJR Am J Roentgenol. 2020 02; 214(2):383-389.
    View in: PubMed
    Score: 0.063
  3. Pandey P, Pandey A, Shao N, Varzaneh FN, Ghasabeh MA, Zharghampour M, Khoshpouri P, Fouladi D, Eng J, O'Broin-Lennon AM, Canto M, Hruban RH, Kamel IR. Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms. Eur Radiol. 2019 Sep; 29(9):4660-4669.
    View in: PubMed
    Score: 0.060
  4. Khoshpouri P, Ameli S, Ghasabeh MA, Pandey A, Zarghampour M, Varzaneh FN, Jacob A, Pandey P, Luo Y, Kamel IR. Correlation between quantitative liver and spleen volumes and disease severity in primary sclerosing cholangitis as determined by Mayo risk score. Eur J Radiol. 2018 Nov; 108:254-260.
    View in: PubMed
    Score: 0.059
  5. Pandey A, Pandey P, Ghasabeh MA, Zarghampour M, Khoshpouri P, Ameli S, Luo Y, Kamel IR. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization? Radiology. 2018 12; 289(3):843-853.
    View in: PubMed
    Score: 0.058
  6. Li A, Xing W, Li H, Hu Y, Hu D, Li Z, Kamel IR. Subtype Differentiation of Small (= 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI. AJR Am J Roentgenol. 2018 09; 211(3):614-623.
    View in: PubMed
    Score: 0.057
  7. Zarghampour M, Fouladi DF, Pandey A, Ghasabeh MA, Pandey P, Varzaneh FN, Khoshpouri P, Shao N, Pan L, Grimm R, Kamel IR. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. J Magn Reson Imaging. 2018 10; 48(4):1080-1090.
    View in: PubMed
    Score: 0.057
  8. Pandey A, Pandey P, Aliyari Ghasabeh M, Najmi Varzaneh F, Shao N, Khoshpouri P, Zarghampour M, Fouladi DF, Liddell R, Kamel IR. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival. Radiology. 2018 Jul; 288(1):109-117.
    View in: PubMed
    Score: 0.056
  9. Pandey P, Pandey A, Varzaneh FN, Ghasabeh MA, Fouladi D, Khoshpouri P, Shao N, Zarghampour M, Hruban RH, Canto M, O'Broin-Lennon AM, Kamel IR. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort. Eur Radiol. 2018 Jul; 28(7):2790-2800.
    View in: PubMed
    Score: 0.056
  10. Fabrega-Foster KE, Agarwal S, Rastegar N, Haverstock D, Agris JM, Kamel IR. Efficacy and safety of gadobutrol-enhanced MRA of the renal arteries: Results from GRAMS (Gadobutrol-enhanced renal artery MRA study), a prospective, intraindividual multicenter phase 3 blinded study. J Magn Reson Imaging. 2018 02; 47(2):572-581.
    View in: PubMed
    Score: 0.053
  11. Zhu X, Sobhani F, Xu C, Pan L, Ghasebeh MA, Kamel IR. Quantitative volumetric functional MR imaging: an imaging biomarker of early treatment response in hypo-vascular liver metastasis patients after yttrium-90 transarterial radioembolization. Abdom Radiol (NY). 2016 08; 41(8):1495-504.
    View in: PubMed
    Score: 0.050
  12. Pozzessere C, Castaños Gutiérrez SL, Corona-Villalobos CP, Righi L, Xu C, Lennon AM, Wolfgang CL, Hruban RH, Goggins M, Canto MI, Kamel IR. Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts. J Comput Assist Tomogr. 2016 Jul-Aug; 40(4):505-12.
    View in: PubMed
    Score: 0.050
  13. Xu C, Sobhani F, Murano E, Corona-Villalobos C, Pozzessere C, Rastegar N, Kamel IR. Liver Malignancies Treated With Intra-Arterial Therapy: Assessment of Early Response as Quantified by Volumetric Enhancement Using Gadoxetate Disodium. J Comput Assist Tomogr. 2016 Mar-Apr; 40(2):206-11.
    View in: PubMed
    Score: 0.049
  14. Corona-Villalobos CP, Halappa VG, Geschwind JF, Bonekamp S, Reyes D, Cosgrove D, Pawlik TM, Kamel IR. Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. Eur Radiol. 2015 Feb; 25(2):380-90.
    View in: PubMed
    Score: 0.044
  15. Ou HY, Bonekamp S, Bonekamp D, Corona-Villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis. AJR Am J Roentgenol. 2013 Oct; 201(4):W596-602.
    View in: PubMed
    Score: 0.041
  16. Corona-Villalobos CP, Pan L, Halappa VG, Bonekamp S, Lorenz CH, Eng J, Kamel IR. Agreement and reproducibility of apparent diffusion coefficient measurements of dual-b-value and multi-b-value diffusion-weighted magnetic resonance imaging at 1.5 Tesla in phantom and in soft tissues of the abdomen. J Comput Assist Tomogr. 2013 Jan-Feb; 37(1):46-51.
    View in: PubMed
    Score: 0.039
  17. Halappa VG, Bonekamp S, Corona-Villalobos CP, Li Z, Mensa M, Reyes D, Eng J, Bhagat N, Pawlik TM, Geschwind JF, Kamel IR. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology. 2012 Jul; 264(1):285-94.
    View in: PubMed
    Score: 0.038
  18. Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data. Radiology. 2011 Sep; 260(3):752-61.
    View in: PubMed
    Score: 0.036
  19. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging. 2004 Nov-Dec; 29(6):663-8.
    View in: PubMed
    Score: 0.022
  20. Wang J, Hu S, Liang P, Hu X, Shen Y, Peng Y, Kamel I, Li Z. R2* mapping and reduced field-of-view diffusion-weighted imaging for preoperative assessment of nonenlarged lymph node metastasis in rectal cancer. NMR Biomed. 2024 10; 37(10):e5174.
    View in: PubMed
    Score: 0.022
  21. Kamel IR, Hochman MG, Keogan MT, Eng J, Longmaid HE, DeWolf W, Edelman RR. Accuracy of breath-hold magnetic resonance imaging in preoperative staging of organ-confined renal cell carcinoma. J Comput Assist Tomogr. 2004 May-Jun; 28(3):327-32.
    View in: PubMed
    Score: 0.022
  22. Kamel IR, Bluemke DA, Ramsey D, Abusedera M, Torbenson M, Eng J, Szarf G, Geschwind JF. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003 Sep; 181(3):708-10.
    View in: PubMed
    Score: 0.021
  23. Kamel IR, Bluemke DA. Magnetic resonance imaging of the liver: assessing response to treatment. Top Magn Reson Imaging. 2002 Jun; 13(3):191-200.
    View in: PubMed
    Score: 0.019
  24. Peng Y, Xu C, Hu X, Shen Y, Hu D, Kamel I, Li Z. Reduced Field-of-View Diffusion-Weighted Imaging in Histological Characterization of Rectal Cancer: Impact of Different Region-of-Interest Positioning Protocols on Apparent Diffusion Coefficient Measurements. Eur J Radiol. 2020 Jun; 127:109028.
    View in: PubMed
    Score: 0.016
  25. Peng Y, Tang H, Hu X, Shen Y, Kamel I, Li Z, Hu D. Rectal Cancer Invasiveness: Whole-Lesion Diffusion-Weighted Imaging (DWI) Histogram Analysis by Comparison of Reduced Field-of-View and Conventional DWI Techniques. Sci Rep. 2019 12 10; 9(1):18760.
    View in: PubMed
    Score: 0.016
  26. Parekh VS, Macura KJ, Harvey SC, Kamel IR, Ei-Khouli R, Bluemke DA, Jacobs MA. Multiparametric deep learning tissue signatures for a radiological biomarker of breast cancer: Preliminary results. Med Phys. 2020 Jan; 47(1):75-88.
    View in: PubMed
    Score: 0.016
  27. Li H, Li A, Zhu H, Hu Y, Li J, Xia L, Hu D, Kamel IR, Li Z. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma. Acad Radiol. 2019 05; 26(5):632-639.
    View in: PubMed
    Score: 0.014
  28. Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology. 2018 09; 155(3):740-751.e2.
    View in: PubMed
    Score: 0.014
  29. Zghaib T, Shahid A, Pozzessere C, Porter KK, Chu LC, Eng J, Calkins H, Kamel IR, Nazarian S, Zimmerman SL. Validation of contrast-enhanced time-resolved magnetic resonance angiography in pre-ablation planning in patients with atrial fibrillation: comparison with traditional technique. Int J Cardiovasc Imaging. 2018 Sep; 34(9):1451-1458.
    View in: PubMed
    Score: 0.014
  30. Jacobs MA, Macura KJ, Zaheer A, Antonarakis ES, Stearns V, Wolff AC, Feiweier T, Kamel IR, Wahl RL, Pan L. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad Radiol. 2018 11; 25(11):1405-1414.
    View in: PubMed
    Score: 0.014
  31. Chu LC, Corona-Villalobos CP, Halushka MK, Zhang Y, Pozzessere C, Kamel IR, Pozios I, Van Der Geest RJ, Gai N, Abraham RM, Abraham TP, Bluemke DA, Zimmerman SL. Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):653-660.
    View in: PubMed
    Score: 0.013
  32. Fan KY, Wild AT, Halappa VG, Kumar R, Ellsworth S, Ziegler M, Garg T, Rosati LM, Su Z, Hacker-Prietz A, Pawlik TM, Cosgrove DP, Hong KK, Kamel IR, Geschwind JF, Herman JM. Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization. Contemp Clin Trials. 2016 09; 50:143-9.
    View in: PubMed
    Score: 0.013
  33. Masica DL, Dal Molin M, Wolfgang CL, Tomita T, Ostovaneh MR, Blackford A, Moran RA, Law JK, Barkley T, Goggins M, Irene Canto M, Pittman M, Eshleman JR, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Ahuja N, Makary MA, Weiss MJ, Hirose K, Cameron JL, Rezaee N, He J, Joon Ahn Y, Wu W, Wang Y, Springer S, Diaz LL, Papadopoulos N, Hruban RH, Kinzler KW, Vogelstein B, Karchin R, Lennon AM. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts. J Am Med Inform Assoc. 2017 01; 24(1):145-152.
    View in: PubMed
    Score: 0.012
  34. Rastegar N, Te Riele AS, James CA, Bhonsale A, Murray B, Tichnell C, Calkins H, Tandri H, Bluemke DA, Kamel IR, Zimmerman SL. Fibrofatty Changes: Incidence at Cardiac MR Imaging in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Radiology. 2016 08; 280(2):405-12.
    View in: PubMed
    Score: 0.012
  35. Corona-Villalobos CP, Sorensen LL, Pozios I, Chu L, Eng J, Abraham MR, Abraham TP, Kamel IR, Zimmerman SL. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography. Int J Cardiovasc Imaging. 2016 Jun; 32(6):945-54.
    View in: PubMed
    Score: 0.012
  36. Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Hutfless S, Salamone A, Kiswani V, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Wolfgang CL. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol. 2014 Oct; 21(11):3668-3674.
    View in: PubMed
    Score: 0.011
  37. Hyder O, Dodson RM, Nathan H, Herman JM, Cosgrove D, Kamel I, Geschwind JF, Pawlik TM. Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study. J Am Coll Surg. 2013 Nov; 217(5):896-906.
    View in: PubMed
    Score: 0.010
  38. Hyder O, Dodson RM, Weiss M, Cosgrove DP, Herman JM, Geschwind JH, Kamel IR, Pawlik TM. Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma. J Gastrointest Surg. 2013 Oct; 17(10):1774-1783.
    View in: PubMed
    Score: 0.010
  39. Hyder O, Marsh JW, Salem R, Petre EN, Kalva S, Liapi E, Cosgrove D, Neal D, Kamel I, Zhu AX, Sofocleous CT, Geschwind JF, Pawlik TM. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann Surg Oncol. 2013 Nov; 20(12):3779-86.
    View in: PubMed
    Score: 0.010
  40. Kanda M, Sadakari Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwara S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol. 2013 Jun; 11(6):719-30.e5.
    View in: PubMed
    Score: 0.010
  41. Buijs M, Reyes DK, Pawlik TM, Blackford AL, Salem R, Messersmith WA, Weekes CD, Mulcahy M, Kamel IR, Geschwind JF. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2013 Mar 01; 119(5):1042-9.
    View in: PubMed
    Score: 0.010
  42. Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto MI, Goggins M. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013 Jul; 62(7):1024-33.
    View in: PubMed
    Score: 0.010
  43. Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, Cameron A, Gurakar A, Cosgrove D, Choti MA, Geschwind JF, Kamel IR, Pawlik TM. Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol. 2012 Sep; 19(9):2897-907.
    View in: PubMed
    Score: 0.009
  44. Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF. Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol. 2011 Oct 20; 29(30):3960-7.
    View in: PubMed
    Score: 0.009
  45. Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J. 2009 Nov-Dec; 15(6):526-32.
    View in: PubMed
    Score: 0.008
  46. Jacobs MA, Ouwerkerk R, Kamel I, Bottomley PA, Bluemke DA, Kim HS. Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging. 2009 Mar; 29(3):649-56.
    View in: PubMed
    Score: 0.008
  47. Hong K, McBride JD, Georgiades CS, Reyes DK, Herman JM, Kamel IR, Geschwind JF. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Interv Radiol. 2009 Mar; 20(3):360-7.
    View in: PubMed
    Score: 0.007
  48. Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr. 2008 May-Jun; 32(3):347-52.
    View in: PubMed
    Score: 0.007
  49. Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. J Vasc Interv Radiol. 2007 Aug; 18(8):957-63.
    View in: PubMed
    Score: 0.007
  50. Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol. 2007 Feb 07; 13(5):781-4.
    View in: PubMed
    Score: 0.007
  51. Fayad LM, Kawamoto S, Kamel IR, Bluemke DA, Eng J, Frassica FJ, Fishman EK. Distinction of long bone stress fractures from pathologic fractures on cross-sectional imaging: how successful are we? AJR Am J Roentgenol. 2005 Oct; 185(4):915-24.
    View in: PubMed
    Score: 0.006
  52. Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, Thompson R, Bluemke D. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005 Jan; 184(1):121-7.
    View in: PubMed
    Score: 0.006
  53. Li AE, Kamel I, Rando F, Anderson M, Kumbasar B, Lima JA, Bluemke DA. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR Am J Roentgenol. 2004 Mar; 182(3):593-7.
    View in: PubMed
    Score: 0.005
  54. Tekes A, Kamel IR, Chan TY, Schoenberg MP, Bluemke DA. MR imaging features of non-transitional cell carcinoma of the urinary bladder with pathologic correlation. AJR Am J Roentgenol. 2003 Mar; 180(3):779-84.
    View in: PubMed
    Score: 0.005
  55. Kumbasar B, Wu KC, Kamel IR, Lima JA, Bluemke DA. Left ventricular true aneurysm: diagnosis of myocardial viability shown on MR imaging. AJR Am J Roentgenol. 2002 Aug; 179(2):472-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)